Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MYC | P01106 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 4/20 | 0.43 |
| ▸ | RAB9A | P51151 | 4/20 | 0.43 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.40 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.40 |
| ▸ | DHODH | Q02127 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8554492 | 0.77 | MYC (0.51) | MYCALDH1A1TSHRKDM4EUSP2 | |
| SCHEMBL11217790 | 0.71 | MYC (0.69) | MYCALDH1A1KDM4ESOS1MAPT | |
| SCHEMBL7822299 | 0.69 | BCAT2 (0.69) | MYCALDH1A1TSHRKDM4ENPC1 | |
| SCHEMBL106081 | 0.69 | ALDH1A1 (0.56) | MYCALDH1A1TSHRKDM4EUSP2 | |
| SCHEMBL27659760 | 0.69 | BCAT2 (0.69) | MYCALDH1A1TSHRKDM4ENPC1 | |
| SCHEMBL6980584 | 0.69 | BCAT2 (0.63) | MYCALDH1A1TSHRKDM4ENPC1 | |
| SCHEMBL27361722 | 0.69 | BCAT2 (0.58) | MYCTSHRNPC1RAB9ABCAT2 | |
| SCHEMBL9512847 | 0.69 | MYC (1.00) | MYCALDH1A1TSHRKDM4EUSP2 | |
| Hydrochloric Acid SCHEMBL9411948 | 0.68 | ALDH1A1 (0.54) | MYCALDH1A1TSHRKDM4EUSP2 | |
| SCHEMBL7738392 | 0.68 | ALDH1A1 (0.50) | ALDH1A1TSHRKDM4EUSP2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8030360-B2 | Applying 4-(2,4-bistrimethylsilyphenylcarboxamide) benzoic acid; warts, eczema, dandruff | KEMPHYS LTD. (JP) | 2011-10-04 | — | — | US | claimed |
| EP-0768084-B1 | CANCEROUS METASTASIS INHIBITOR | TAIHO PHARMACEUTICAL CO LTD (JP) | 2002-09-11 | — | — | EP | claimed |
| EP-0768084-A1 | CANCEROUS METASTASIS INHIBITOR | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1997-04-16 | — | — | EP | claimed |
| JP-2247185-A | — | — | None | — | — | JP | disclosed |
| US-8105833-B2 | Method for forming organ | RESEARCH FOUNDATION ITSUU LABORATORY (JP) | 2012-01-31 | — | — | US | disclosed |
| US-20110319386-A1 | NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION | BRAINCELLS INC. (US) | 2011-12-29 | — | — | US | disclosed |
| US-20110269717-A1 | NEUROGENESIS BY MODULATING ANGIOTENSIN | BRAINCELLS INC. (US) | 2011-11-03 | — | — | US | disclosed |
| US-8030360-B2 | Applying 4-(2,4-bistrimethylsilyphenylcarboxamide) benzoic acid; warts, eczema, dandruff | KEMPHYS LTD. (JP) | 2011-10-04 | — | — | US | disclosed |
| US-8030360-B2 | Applying 4-(2,4-bistrimethylsilyphenylcarboxamide) benzoic acid; warts, eczema, dandruff | KEMPHYS LTD. (JP) | 2011-10-04 | — | — | US | disclosed |
| US-7998971-B2 | 2-(2-oxopyrrolidin- 1 -yl)-N-(2,3 -dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)acetoamide (MKC-231) and a second active ingredient for treating central or peripheral nervous system disorders increase neurogenesis; synergistic; drug addiction, psychological disorders, transplant rejection | BRAINCELLS INC. (US) | 2011-08-16 | — | — | US | disclosed |
| US-20110092464-A1 | NEUROGENESIS BY MODULATING ANGIOTENSIN | BRAINCELLS INC. (US) | 2011-04-21 | — | — | US | disclosed |
| US-20070270449-A1 | 5 HT RECEPTOR MEDIATED NEUROGENESIS | BRAINCELLS, INC. (US) | 2007-11-22 | — | — | US | disclosed |
| US-20070244143-A1 | MODULATION OF NEUROGENESIS BY NOOTROPIC AGENTS | BRAINCELLS, INC (US) | 2007-10-18 | — | — | US | disclosed |
| CN-1964709-A | Memory fixation promoter | RES FOUND ITSUU LAB (JP) | 2007-05-16 | — | — | CN | disclosed |
| US-20070078083-A1 | MODULATION OF NEUORGENESIS BY HDac INHIBITION | BRAINCELLS, INC. (US) | 2007-04-05 | — | — | US | disclosed |
| US-20070049576-A1 | NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION | BRAINCELLS, INC. (US) | 2007-03-01 | — | — | US | disclosed |
| WO-2005087219-A1 | MEMORY FIXATION ACCELERATOR | RESEARCH FOUNDATION ITSUU LABORATORY (JP) | 2005-09-22 | — | — | WO | disclosed |
| EP-0768084-B1 | CANCEROUS METASTASIS INHIBITOR | TAIHO PHARMACEUTICAL CO LTD (JP) | 2002-09-11 | — | — | EP | disclosed |
| EP-0768084-A1 | CANCEROUS METASTASIS INHIBITOR | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1997-04-16 | — | — | EP | disclosed |
| JP-H02247185-A | NOVEL BENZOIC ACID DERIVATIVE AND PRODUCTION THEREOF | SHUDO KOICHI | 1990-10-02 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319386-A1 | NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION | CHRNB2, CHAT, CHRNB4 | MYC 723/4885ALDH1A1 2164/4885TSHR 302/4885 |
| US-20070270449-A1 | 5 HT RECEPTOR MEDIATED NEUROGENESIS | HTR5A, HTR6, GAP43 | MYC 435/4885ALDH1A1 2530/4885TSHR 292/4885 |
| US-20070078083-A1 | MODULATION OF NEUORGENESIS BY HDac INHIBITION | DCX, BDNF, NTRK2 | MYC 559/4885ALDH1A1 1837/4885TSHR 1561/4885 |
| US-20110092464-A1 | NEUROGENESIS BY MODULATING ANGIOTENSIN | DCX, NGF, BDNF | MYC 791/4885ALDH1A1 1591/4885TSHR 1891/4885 |
| US-20110269717-A1 | NEUROGENESIS BY MODULATING ANGIOTENSIN | NGF, DCX, BDNF | MYC 1566/4885ALDH1A1 1565/4885TSHR 1873/4885 |
| US-20070244143-A1 | MODULATION OF NEUROGENESIS BY NOOTROPIC AGENTS | GAP43, BDNF, DCX | MYC 734/4885ALDH1A1 3011/4885TSHR 856/4885 |
| US-20070049576-A1 | NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION | CHRNB2, CHAT, CHRNB4 | MYC 723/4885ALDH1A1 2164/4885TSHR 302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.